CSF S.A.S.

International subsidiary
ZI Rte. de Paris, Mondeville,  F-14120, France
()33 02 31 70 60 00, 33 01 31 70 60 36 fax, http://www.carrefour.com

Primary SIC: Department Stores, Primary NAICS: Department Stores (except Discount Department Stores)
Description: Retail: Operation of supermarkets

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

CSF S.A.S., News and Information

Study results from S.R. Brozell and colleagues in the area of physical chemistry published.
Chemicals & Chemistry; 1/8/2010; 606 words; ...N-alpha((S-max + 1)(2) - S-min(2)) N-alpha is the number...nonlinear arc factor parameters, and S-min and S-max, tire respectively the minimum...correspond to an underlying linear full-CI CSF expansion dimension of over 10(75...

Research from N. Muthukumar and co-authors provides new data about spinal cord disease.(Report)
Biotech Week; 1/6/2010; 1004 words; ...part of the study. Nurick's grading was used to assess...developed cerebrospinal fluid (CSF) leak following surgery and...function improved by one Nurick's grade in 5 of the 7 patients...patients regarding the risks of s." Muthukumar and colleagues...

New narcolepsy study results reported from E.Y. Joo et al.
Biotech Week; 1/6/2010; 734 words; ...into gray matter, white matter, and cerebrospinal fluid (CSF). These segmented images were then smoothed using a 12...6):552-558). For additional information, contact S.B. Hong, Sungkyunkwan UniversitySchool Medical, Samsung...

Studies from University of Virginia have provided new data on cancer vaccines.
Cancer Vaccine Week; 1/4/2010; 1355 words; ...colony-stimulating factor (GM-CSF) administered locally together...local administration of GM-CSF augments immunogenicity of a...emulsified in incomplete Freund's adjuvant, with or without 110 mu g GM-CSF. Among 119 evaluable patients...

BioVex Appoints Tim Hanke as VP Commercial Operations.
Business Wire; 1/4/2010; 872 words; ...preparing for the commercialization of BioVex's investigational product, OncoVEX (GM-CSF). OncoVEX(GM-CSF) is currently in a pivotal Phase 3 study...hematological malignancies. About OncoVEX (GM-CSF) OncoVEX (GM-CSF) is a first in class...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.